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Abstract
Background: Combined thymic carcinoma is a malignant neoplasm of the thymus recently added to the 4th
edition of the World Health Organization (WHO) classification of tumors of the lung, pleura, thymus and heart.
It involves at least one type of thymic carcinoma and another thymic epithelial tumor. The previously used term
“combined thymic epithelial tumor” has been abandoned.
Case presentation: Here, we present an unusual case of combined thymic carcinoma of the thymus in a 44-year-
old male who had suffered from fever, chest pain, chest tightness and shortness of breath. Magnetic resonance
imaging (MRI) detected a mass approximately 6.4 cm × 4.2 cm in the anterior mediastinum, and a nonencapsulated
tumor approximately 5.0 cm × 3.5 cm × 2.5 cm with an irregular shape was resected. The morphological features
and the immunostaining pattern of the tumor revealed it to be an unusual combined thymic carcinoma consisting
of type AB thymoma and squamous cell carcinoma. There were cysts of various sizes, some of which had crack-like
structures, in the type AB thymoma area. A gradual transition could be seen between these structures and the
squamous cell carcinoma, indicating that the carcinoma portion may have originated from the composition of the
thymoma.
Conclusions: Combined thymic carcinoma composed of type AB thymoma and squamous cell carcinoma is rare,
and the carcinoma portion may have originated from epithelial structures in the type AB thymoma.
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Background
Combined thymic carcinomas are tumors composed
of at least one type of thymic carcinoma and another
thymic epithelial tumor of any type of thymoma or
thymic carcinoma, excluding small cell carcinoma and
large cell neuroendocrine carcinoma [1]. It was pro-
posed that the previously recommended term “com-
bined thymoma” be abandoned because thymomas of
different histological types within the same tumor are
very common, according to the 4th edition of the
World Health Organization (WHO) classification of
tumors of the lung, pleura, thymus and heart [1]. In-
stead, the WHO suggested that all the histological
types present be listed in the diagnosis [1]. For
heterogeneous tumors that consist of a thymic carcin-
oma and a thymoma, the organization proposes the
new term “combined thymic carcinoma.” The most
common combinations are thymic squamous cell car-
cinoma and type B3 thymoma and papillary adenocar-
cinoma or sarcomatoid carcinoma associated with
type A thymoma [1–4]. The different components of
the tumors may show a gradual transition or be
sharply separated from each other [1]. Thymic carcin-
oma occasionally arises in type A thymoma, but com-
bined thymic carcinoma composed of squamous cell
carcinoma and type AB thymoma is extremely rare.
Here, we present a case of combined thymic carcin-
oma composed of type AB thymoma and squamous
cell carcinoma using the diagnostic criteria of the 4th
edition of the WHO classification of tumors of the
lung, pleura, thymus and heart.
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A 44-year-old man was referred to our hospital with a 1-
month history of fever without an obvious cause. In that
period, after he had taken anti-inflammatory agents the
fever subsided to some extent. However, in the week be-
fore presenting to the hospital for diagnosis and treat-
ment, he experienced chest pain, chest tightness,
shortness of breath, severe cough and blood in phlegm
accompanied by vomiting after tiredness. In examination
at the hospital, he reported no muscle weakness. Blood
tests showed neuron-specific enolase (NSE) (19.71 ng/
ml), CA125 (49.61 μ/ml) and Cyfra21-1 (8.42 ng/ml)
levels slightly higher than normal, whereas his CEA and
CA199 levels were normal. The patient underwent sur-
gery, and the tumor was found to have invaded the local
pericardium. No lymph node metastasis or distant me-
tastasis was detected. The patient showed no recurrence
6 months after the surgery.
Materials and methods
The resected samples of the tumor were embedded in
paraffin blocks. The blocks were cut into sections and
stained with alum hematoxylin and eosin for morpho-
logical examination under light microscope. The
immunohistochemistry was examined using an SP-kit
(Maixin Biotechnology, Fuzhou, Fujian, China) accord-
ing to the instruction manual of the developer. The sec-
tions were incubated overnight at 4 °C with the
following primary antibodies: CD1α (1:100, DAKO),
CD3 (1:100, DAKO), CD5 (1:200, DAKO), CD20 (1:100,
DAKO), CD99 (1:200, DAKO), CK (Pan) (1:200, DAKO),
CK19 (1:200, DAKO), CK20 (1:100, DAKO), Ki-67
(1:200, DAKO), p63 (1:100, DAKO) and TdT (1:100,
DAKO). This study was prospectively performed and
approved by the institutional ethics committees of China
Medical University and conducted in accordance with
the ethical guidelines of the Declaration of Helsinki.
Results
Imaging and gross features
Figure 1 shows the X-ray and MRI findings. The X-ray
showed a widened mediastinum without displacement
(A, B). The lung field was clear and the size of the heart
was normal. MRI detected a mass approximately
6.4 cm × 4.2 cm in the anterior mediastinum beside the
right part of the heart (C, D). The margins between
the mass and the pericardium were not clear. The
surgical records indicated that the tumor was located
on the right side of the anterior mediastinal and was
Fig. 1 The imaging of the tumor. The X-ray shows a widened mediastinum without displacement (a, b). MRI detected a mass that was
approximately 6.4 cm × 4.2 cm in the anterior mediastinum beside the right part of the heart (c, d). The margins between the mass and
the pericardium were not clear
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closely attached to part of the right lung, the superior
vena cava and the ascending aorta. The resected
tumor was approximately 5.0 cm × 3.5 cm × 2.5 cm. It
was nonencapsulated with an irregular shape. The cut
surface of the mass was gray and firm. Hemorrhage,
necrosis and cyst formation were observed in some
areas.
Microscopic features
Figure 2 shows that thymoma accounted for approxi-
mately 50% of the tumor tissue. Panel A shows that the
histological type of the thymoma was AB thymoma.
Panel B shows that the type A region of the thymoma
consisted mainly of oval tumor cells arranged in nests
with a few dispersed lymphocytes. The tumor cells
had bland nuclei, dispersed chromatin and incon-
spicuous nucleoli. Panels C and D show that the type
B area consisted mainly of lymphocytes with a few
small polygonal epithelial cells with bland nuclei. As
shown in Fig. 3, another part of the tumor was kera-
tinizing squamous cell carcinoma, accounting for ap-
proximately 50% of the tumor tissue (A, B). There
was marked necrosis and hemorrhage in this region
of the tumor (B). Fig. 4 shows that in the area of the
AB thymoma, there were cysts of various sizes, some
of which had crack-like structures (A, B). There was
a gradual transition between these structures in the
thymoma and squamous cell carcinoma (A, B), which
indicates that the squamous cell carcinoma may have
originated in the thymoma rather than being a meta-
static tumor.
Immunophenotype
Figure 5 shows the immunostaining pattern of the
tumor. CD1α was positive mainly in the type B area in
type AB thymoma (Fig. 5a). Cells positive for CD3
(Fig. 5b) and CD5 (Fig. 5c) were also seen mainly in the
type B area in type AB thymoma. There were very few
CD20-positive cells in the tumor tissue (Fig. 5d). The
pattern of CD99 (Fig. 5e) and TdT (Fig. 5f ) immuno-
staining was similar to that of CD1α, CD3 and CD5 in
type AB thymoma and squamous cell carcinoma. These
results indicate that the immature T lymphocytes were
found mainly in the type B area in type AB thymoma.
CK (Fig. 5g) and CK19 (Fig. 5h) were positive both in
the type A and B areas of type AB thymoma, but the im-
munostaining was stronger and more diffuse in the type
A area than in the type B area. CK20 was negative
(Fig. 5i). p63 was positive in both type AB thymoma and
squamous cell carcinoma (Fig. 5j). CD5 and CD117 were
negative in squamous cell carcinoma. The Ki67 index in
squamous cell carcinoma was approximately 50%
(Fig. 5k). It was nearly 100% in lymphocytes in the type
B area in type AB thymoma but was very low (approxi-
mately 3%) in epithelial cells in the type A area (Fig. 5l).
We also examined the genetic profile of the tumor via
immunohistochemistry. Figure 6 shows that the immu-
nostaining patterns of EGFR, c-erbB-2 and p53 in type
AB thymoma and thymic carcinoma were similar, but
there was greater MLH1 and MSH2 loss in thymic car-
cinoma (>10%) than in type AB thymoma (<10%), which
indicates the presence of microsatellite instability in
thymic carcinoma but not type AB thymoma.
Fig. 2 Morphological features of the tumor. Part of the tumor was composed of AB thymoma (a). The type A region of the thymoma consisted
mainly of oval tumor cells arranged in nests with a few dispersed lymphocytes (b). The tumor cells had bland nuclei, dispersed chromatin and
inconspicuous nucleoli (b). The type B area consisted mainly of lymphocytes with few small polygonal epithelial cells with bland nuclei (c, d)
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Discussion
Primary thymic carcinomas are rare malignant neo-
plasms of the mediastinum, and combined thymic
carcinomas are even less common [1–4]. Almost all re-
ported cases of combined thymic carcinomas were lo-
cated in the anterior mediastinum [1]. The clinical
features of the tumors are the same as those of thymic
epithelial tumors of a single histological type [1, 5, 6].
Most components of carcinoma in combined thymic
carcinomas are squamous cell carcinomas, and type B2
and B3 thymomas account for most of these compo-
nents [1–4]. Thymic carcinoma combined with type A
thymoma is rare, but combined thymic carcinoma com-
posed of squamous cell carcinoma and type AB thym-
oma is even less common. The macroscopic features
of combined thymic carcinoma are the same as those
of tumors of a single histological type [1–4]. The case
reported here was diagnosed as an unusual combined
thymic carcinoma composed of type AB thymoma
and squamous cell carcinoma according to the 4th
edition of the WHO classification of tumors of the
lung, pleura, thymus and heart. This type of thymic
tumor is new to this edition, and it is suggested that
the formerly used term “combined thymic epithelial
tumor” not be used anymore because thymomas
showing different histological types in the same tumor
are very common.
In the current case, histological and immunohisto-
chemical findings revealed a combination of type AB
thymoma and squamous cell carcinoma. There were
cysts of various sizes, some of which had crack-like
structures in the type AB area of thymoma, with a
gradual transition between these structures and the
squamous cell carcinoma. This indicates that the
squamous cell carcinoma may have originated from
the composition of the thymoma tissue. However,
whether the carcinoma components originated from
the epithelial cells in the thymomas and what mecha-
nisms are involved remain unclear. Here, we found
that CD5 and CD117 were negative in thymic carcin-
oma. Metastatic carcinoma needed to be ruled out.
According to the 4th edition of the WHO classifica-
tion of tumors of the lung, pleura, thymus and heart,
the positive rates of CD5 and CD117 in thymic
Fig. 3 Morphological features of the tumor. Part of the tumor was composed of keratinizing squamous cell carcinoma (a,b) with necrosis and
hemorrhage (b)
Fig. 4 Morphological features of the tumor. There were cysts of various sizes, some of which had crack-like structures, in the area of the
AB thymoma (a, b). A gradual transition was found between these structures in the thymoma and squamous cell carcinoma. The white
arrows indicate the epithelial cells of the cystic structures in the thymic thymoma and the black arrows indicate the carcinoma cells of
the squamous cell carcinoma
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squamous cell carcinoma are 74% and 84%, respect-
ively [1]. The physical examination of the patient did
not indicate the presence of tumor in other part of
the body other than the anterior mediastinum. The
pathological findings indicated a transition between
the squamous cell carcinoma and the cysts in the
type AB thymoma. These findings suggest that the
squamous cell carcinoma was originally part of a
combined thymic tumor rather than a metastatic
tumor. Thymic carcinoma can arise from thymic
cysts. In this case, we found numerous structures of
cysts in the portion of the type AB thymoma in the
tumor tissue. There was a transition between this sec-
tion and the squamous cell carcinoma. It indicated
that there was a close relationship between these dif-
ferent tumor parts and that the portion of carcinoma
Fig. 5 Immunostaining pattern of the tumor. CD1α was positive mainly in the cytoplasm of the T lymphocyte cells in the type B area in type AB
thymoma (a). The immunostaining patterns of CD3, CD5, CD99 and TdT were similar to that of CD1α, which indicates immature T lymphocyte
cells in these areas (b, c, e, f). There were very few CD20-positive cells in the tumor tissue (d). CK and CK19 were positive in the cytoplasm of the
epithelial cells in both the type A and B areas of type AB thymoma, but the immunostaining was stronger and more diffuse in the type A area
than in the type B area (g, h). CK20 was negative (i). P63 was positive mainly in the nucleus of the epithelial cells in both type AB thymoma and
squamous cell carcinoma (j). The Ki67 index in squamous cell carcinoma was approximately 50% (k). It was nearly 100% in the lymphocytes in
the type B area in type AB thymoma but was very low at (approximately 3%) in the epithelial cells in the type A area (l)
Fig. 6 Genetic profile of the tumor via immunohistochemistry. The immunostaining patterns of EGFR, c-erbB-2 and P53 in type AB thymoma and
thymic carcinoma were similar, but there was greater MLH1 and MSH2 loss in thymic carcinoma (>10%) than in type AB thymoma (<10%)
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may have originated in the thymoma. However, it
does not entirely exclude the possibility that the carcin-
oma may have originated from a thymic cyst because the
cyst might also have come from the structures of the cysts
in the thymoma. Actually, in this case, the squamous cell
carcinoma showed cystic change and hemorrhage,
although we did not find a clear lesion involving a thymic
cyst. Interestingly, CD5 and CD117 were both negative in
the squamous cell carcinoma, which is often positive for
these two markers. Whether there are different features of
these two markers in the squamous cell carcinoma that
originated from a thymic cyst compared with that in
thymic squamous carcinoma needs to be further clarified.
Moreover, the origination and oncogenesis of thymic
squamous carcinoma are not fully understood. No system-
atic study has been done on the genetic changes in the
components of combined thymic carcinoma to provide
clues and evidence to answer these questions. Some stud-
ies have shown that the genetic alterations found in
thymic squamous carcinomas of the thymus are distinct-
ive from those in tumors of the lung, head, and neck, al-
though their morphological features are similar [7–9].
Conclusion
Combined thymic carcinomas are epithelial thymic tu-
mors that consist of at least one type of thymic carcinoma
and another thymic epithelial tumor. Although most of
these tumors are composed of squamous cell carcinoma
with type B2 or B3 thymomas, our study indicates that
type AB thymoma can also be combined with squamous
cell carcinoma in the anterior mediastinum. The gradual
transition of the cystic structures in type AB thymoma
with squamous cell carcinoma points to the possible
origin of the malignant part of the thymoma, although
systematic genetic analysis is needed to understand the
etiology and carcinogenesis of these tumors.
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